US09076G2030 - ADR
BIOPHYTIS SA-ADR
NASDAQ:BPTS (4/25/2024, 7:00:01 PM)
After market: 7.92 -0.3 (-3.65%)8.22
-1.48 (-15.28%)
Biophytis SA operates as a clinical-stage biotechnology company. The company is headquartered in Paris, Ile-De-France and currently employs 26 full-time employees. The company went IPO on 2015-07-13. The firm is a biotechnology entity specialized in the development of drug candidates to treat ageing diseases. Its two programs relate to sarcopenia (loss of muscle functionality) and Age Related Macular Degeneration (ARMD). Biophytis SA is engaged in the clinical and regulatory development of its drug candidates, such as Sarconeos (BIO101) and Macuneos (BIO201), simultaneously in the United States and domestic market.
BIOPHYTIS SA-ADR
14 avenue de l'Opera
Paris ILE-DE-FRANCE 75252
P: 33141836600
CEO: Stanislas Veillet
Employees: 26
Website: https://www.biophytis.com/
Get insights into the top gainers and losers of Thursday's pre-market session.
Pre-market stock movers are a great way to start Thursday as we check out all of the hottest news moving shares this morning!
It's time to start ofd the trading week with a look at the biggest pre-market stock movers traders need to watch on Monday morning!
Friday's pre-market session: top gainers and losers
Pre-market stock movers are worth diving into on Wednesday morning to get ready for all of the hottest news moving shares today!
Vincerx Pharma stock is falling hard on Tuesday after the company failed to impress VINC shareholders with its latest clinical trial update.
Here you can normally see the latest stock twits on BPTS, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: